TrialBlood cancer journal2020

Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma.

Siyang Leng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.